| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | Chief Medical Officer, Head of Therapeutics Discovery and Development | Share Option (right to buy) | 60K | Jul 25, 2022 | Direct | ||
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 20.9K | May 24, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | May 24, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| ATHA | Athira Pharma, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| WVE | Wave Life Sciences Ltd. | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Chief Medical Officer, Head of Therapeutics Discovery and Development |
| ATHA | Athira Pharma, Inc. | May 20, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| WVE | Wave Life Sciences Ltd. | May 4, 2022 | 2 | -$28.7K | 4 | May 6, 2022 | Chief Medical Officer, Head of Therapeutics Discovery and Development |
| ATHA | Athira Pharma, Inc. | Mar 18, 2022 | 1 | $0 | 4 | Mar 21, 2022 | Director |
| ATHA | Athira Pharma, Inc. | Mar 18, 2022 | 0 | $0 | 3 | Mar 21, 2022 | Director |
| WVE | Wave Life Sciences Ltd. | Feb 16, 2022 | 1 | -$24.5K | 4 | Feb 18, 2022 | Chief Medical Officer, Head of Therapeutics Discovery and Development |
| WVE | Wave Life Sciences Ltd. | Jan 1, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Chief Medical Officer, Head of Therapeutics Discovery and Development |